Skip to main content
. 2022 Aug;28(8):10.18553/jmcp.2022.28.8.903. doi: 10.18553/jmcp.2022.28.8.903

TABLE 3.

Votes on Comparative Clinical Effectiveness Questions

Question Yes No
Given the currently available evidence, is the evidence adequate to demonstrate that the net health benefit of molnupiravir is superior to that provided by symptomatic care alone? 2 11
Given the currently available evidence, is the evidence adequate to demonstrate that the net health benefit of Paxlovid is superior to that provided by symptomatic care alone? 13 0
Given the currently available evidence, is the evidence adequate to demonstrate that the net health benefit of fluvoxamine is superior to that provided by symptomatic care alone? 7 6